Michael Scolaro

Michael Scolaro

Nov 29, 2017

Group 6 Copy 180
1
References
  • 1. https://www.ncbi.nlm.nih.gov/pubmed/26558876
  • 2. https://www.ncbi.nlm.nih.gov/pubmed/26558876
Please wait...

About This Project

We hypothesize that targeted delivery of Curcumin to antigen presenting cells in the immune system can suppress tumor growth for a variety of cancers. This study will examine tumor responses to Curcumin in a colon cancer mouse model when given alone or in combination with an FDA-approved immune Checkpoint Inhibitor. Positive results will lead to Fast-Track FDA applications for human and companion pet animal cancer trials.

Blast off!

Browse Other Projects on Experiment

Related Projects

Personalized Cancer and Viral Therapy: Clostridium-based Cell Delivery System coupled to CRISPR/Cas9 Nanotherapeutic

One of the fundamental weaknesses in cancer treatment or any therapy based at the cellular level is entering...

From Minerals to Medicines: A New Technology for Heavy Metal Pollution Remediation

This is the first part of a multi-phase experiment in which I will prove that substances isolated from plant...

Does bias about medical diagnosis link to expectations of mental health problems for infants and their parents?

If doctors think infants will have lower skill (e.g., less able to look and to smile at parents), does that...

Backer Badge Funded